id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-5843-0002,FDA,FDA-2019-N-5843,"Pharmacia and Upjohn Co., et al.; Withdrawal of Approval of 19 New Drug Applications; Correction",Notice,Correction,2020-11-18T05:00:00Z,2020,11,2020-11-18T05:00:00Z,,2020-11-18T13:15:03Z,2020-25413,0,0,09000064849661a2
FDA-2019-N-5843-0001,FDA,FDA-2019-N-5843,"Pharmacia and Upjohn Co., et al.; Withdrawal of Approval of 19 New
Drug Applications",Notice,Withdrawal,2020-01-08T05:00:00Z,2020,1,2020-01-08T05:00:00Z,,2020-01-08T14:23:56Z,2020-00075,0,0,090000648427be32